Illumina Cash Conversion Cycle 2011-2026 | ILMN

Annual Cash Conversion Cycle Illumina

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
142	102	82.9	59.1	-	130	128	139	135	-	127	119	143	158

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
158	59.1	122

Quarterly Cash Conversion Cycle Illumina

2025-Q3	2025-Q2	2024-Q3	2024-Q2	2024-Q1	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
157	150	-	139	143	128	121	-	-	96.7	80.7	-	92.1	94.4	47.4	-	144	185	144	54.9	132	135	130	54.1	127	129	124	48.2	121	126	121	59.2	117	109	66.8	-	128	121	112	51.5	122	126	118	56.3	111	123	133	63.4	163	167	147	58.4	170	141	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
185	47.4	114

Cash Conversion Cycle of other stocks in the Diagnostics research industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Agilent Technologies A	111	$ 115.48	0.82 %	$ 35.1 B	USA
Centogene N.V. CNTG	50.2	-	-6.23 %	$ 30.6 M	Germany
Burning Rock Biotech Limited BNR	149	$ 16.2	-0.61 %	$ 175 M	China
Biodesix BDSX	41.7	$ 15.07	2.1 %	$ 1.95 B	USA
Aspira Women's Health AWH	1.01 K	-	-6.19 %	$ 10.5 M	USA
Co-Diagnostics CODX	-2.46 K	$ 4.4	101.83 %	$ 5.85 M	USA
Castle Biosciences CSTL	45.9	$ 24.84	-0.84 %	$ 690 M	USA
DarioHealth Corp. DRIO	115	$ 8.4	3.7 %	$ 33.5 M	Israel
BioNano Genomics BNGO	166	$ 1.2	0.84 %	$ 6.53 M	USA
Akumin AKU	36.1	-	-17.87 %	$ 25.9 M	Canada
Charles River Laboratories International CRL	65	$ 173.89	-0.58 %	$ 8.62 B	USA
Accelerate Diagnostics AXDX	364	-	-61.36 %	$ 2.46 M	USA
DexCom DXCM	134	$ 62.22	-0.24 %	$ 24.3 B	USA
Fulgent Genetics FLGT	42.4	$ 16.82	2.31 %	$ 509 M	USA
Biomerica BMRA	172	$ 2.17	-0.91 %	$ 4.98 M	USA
Global Cord Blood Corporation CO	184	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	142	-	0.12 %	$ 80.1 M	China
Exact Sciences Corporation EXAS	42.5	-	-	$ 19.8 B	USA
PRA Health Sciences, Inc. PRAH	1.21 K	-	-	$ 10.7 B	USA
DermTech DMTK	66.7	-	-11.32 %	$ 2.94 M	USA
Quest Diagnostics Incorporated DGX	39.5	$ 198.02	0.17 %	$ 22 B	USA
Guardant Health GH	79.6	$ 93.83	2.94 %	$ 11.8 B	USA
Enzo Biochem ENZ	154	-	-8.98 %	$ 14.8 K	USA
Lantheus Holdings LNTH	97.3	$ 76.1	0.53 %	$ 5.14 B	USA
Biocept BIOC	78.1	-	-13.05 %	$ 7.29 M	USA
Medpace Holdings MEDP	50.4	$ 498.34	1.81 %	$ 14.4 B	USA
Heska Corporation HSKA	138	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	104	-	-20.0 %	$ 1.06 M	USA
Interpace Biosciences IDXG	62.9	$ 1.96	5.82 %	$ 8.67 M	USA
Mettler-Toledo International MTD	66.4	$ 1 259.94	-1.11 %	$ 26 B	Schweiz
ICON Public Limited Company ICLR	62	$ 114.19	2.49 %	$ 9.42 B	Irlanda
IDEXX Laboratories IDXX	103	$ 569.55	0.87 %	$ 45.8 B	USA
Neogen Corporation NEOG	150	$ 9.41	0.21 %	$ 2.04 B	USA
IQVIA Holdings IQV	73.9	$ 173.26	0.5 %	$ 29.8 B	USA
Pacific Biosciences of California PACB	185	$ 1.34	-0.74 %	$ 402 M	USA
Koninklijke Philips N.V. PHG	89	$ 27.11	-0.66 %	$ 20 B	Niderland
QIAGEN N.V. QGEN	122	-	-	$ 10.6 B	Niderland
Motus GI Holdings MOTS	3.45 K	-	-34.28 %	$ 263 K	Israel
Chembio Diagnostics CEMI	111	-	0.22 %	$ 16.8 M	USA
Laboratory Corporation of America Holdings LH	40.3	$ 273.72	0.36 %	$ 22.8 B	USA
Myriad Genetics MYGN	49.3	$ 4.75	3.49 %	$ 440 M	USA
Sotera Health Company SHC	33.5	$ 14.96	0.61 %	$ 4.25 B	USA
NeoGenomics NEO	82.4	$ 8.0	3.23 %	$ 1.02 B	USA
National Research Corporation NRC	29.4	$ 17.16	-1.04 %	$ 384 M	USA